Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Goodwill (2016 - 2025)

Historic Goodwill for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Q3 2025 value amounting to $3.4 million.

  • Amphastar Pharmaceuticals' Goodwill rose 454.55% to $3.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.4 million, marking a year-over-year increase of 454.55%. This contributed to the annual value of $3.0 million for FY2024, which is 519.28% down from last year.
  • Amphastar Pharmaceuticals' Goodwill amounted to $3.4 million in Q3 2025, which was up 454.55% from $3.4 million recorded in Q2 2025.
  • Over the past 5 years, Amphastar Pharmaceuticals' Goodwill peaked at $3.8 million during Q2 2021, and registered a low of $2.9 million during Q3 2022.
  • In the last 5 years, Amphastar Pharmaceuticals' Goodwill had a median value of $3.2 million in 2023 and averaged $3.3 million.
  • Per our database at Business Quant, Amphastar Pharmaceuticals' Goodwill tumbled by 2046.88% in 2022 and then skyrocketed by 856.5% in 2025.
  • Quarter analysis of 5 years shows Amphastar Pharmaceuticals' Goodwill stood at $3.3 million in 2021, then dropped by 5.64% to $3.1 million in 2022, then grew by 2.88% to $3.2 million in 2023, then fell by 5.19% to $3.0 million in 2024, then rose by 11.64% to $3.4 million in 2025.
  • Its last three reported values are $3.4 million in Q3 2025, $3.4 million for Q2 2025, and $3.2 million during Q1 2025.